BOLT Insider Trading Activity and SEC Form 4 Filings
BOLT insider trading summary
Over the past 12 months, insiders at Bolt Biotherapeutics, Inc. (BOLT) reported 9 sales worth $128K by 3 insiders and 4 open-market purchases worth $6K by 2 insiders on SEC Form 4. Net insider selling was $123K.
Latest BOLT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 18, 2026 | Grant Yonehiro | Chief Operating Officer | Sell | $22K (6,850 @ $3.24) |
| Sep 18, 2026 | William P. Quinn | President, CEO and CFO | Sell | $30K (9,132 @ $3.24) |
| Sep 18, 2026 | Sarah Nemec | Senior VP, Finance and PAO | Sell | $13K (4,077 @ $3.24) |
| Sep 17, 2026 | Sarah Nemec | Senior VP, Finance and PAO | Sell | $10K (2,922 @ $3.32) |
| Sep 17, 2026 | Grant Yonehiro | Chief Operating Officer | Sell | $16K (4,909 @ $3.32) |
| Sep 17, 2026 | William P. Quinn | President, CEO and CFO | Sell | $22K (6,545 @ $3.32) |
| Sep 16, 2026 | Grant Yonehiro | Chief Operating Officer | Sell | $5K (1,417 @ $3.77) |
| Sep 16, 2026 | William P. Quinn | President, CEO and CFO | Sell | $7K (1,889 @ $3.77) |
| Sep 16, 2026 | Sarah Nemec | Senior VP, Finance and PAO | Sell | $3K (843 @ $3.77) |
| Jun 5, 2026 | Sarah Nemec | Senior VP, Finance and PAO | Buy | $2K (509 @ $3.88) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.